ZA200509780B - Processes for making caralluma extracts and uses - Google Patents
Processes for making caralluma extracts and uses Download PDFInfo
- Publication number
- ZA200509780B ZA200509780B ZA200509780A ZA200509780A ZA200509780B ZA 200509780 B ZA200509780 B ZA 200509780B ZA 200509780 A ZA200509780 A ZA 200509780A ZA 200509780 A ZA200509780 A ZA 200509780A ZA 200509780 B ZA200509780 B ZA 200509780B
- Authority
- ZA
- South Africa
- Prior art keywords
- composition
- caralluma
- extract
- solvent
- extraction
- Prior art date
Links
- 241000517186 Caralluma Species 0.000 title claims description 227
- 239000000284 extract Substances 0.000 title claims description 199
- 238000000034 method Methods 0.000 title claims description 163
- 230000008569 process Effects 0.000 title claims description 136
- 229930182470 glycoside Natural products 0.000 claims description 146
- 239000002904 solvent Substances 0.000 claims description 125
- 238000000605 extraction Methods 0.000 claims description 110
- 150000002338 glycosides Chemical class 0.000 claims description 96
- 239000011347 resin Substances 0.000 claims description 88
- 229920005989 resin Polymers 0.000 claims description 88
- 239000000203 mixture Substances 0.000 claims description 81
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 73
- 239000000463 material Substances 0.000 claims description 63
- 241000196324 Embryophyta Species 0.000 claims description 61
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 claims description 57
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical group CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 claims description 55
- -1 pregnane glycosides Chemical class 0.000 claims description 50
- 239000007787 solid Substances 0.000 claims description 26
- 239000011877 solvent mixture Substances 0.000 claims description 25
- 238000000227 grinding Methods 0.000 claims description 22
- 239000000546 pharmaceutical excipient Substances 0.000 claims description 22
- 241000894007 species Species 0.000 claims description 22
- 238000001035 drying Methods 0.000 claims description 21
- 238000001704 evaporation Methods 0.000 claims description 18
- 230000008020 evaporation Effects 0.000 claims description 18
- 238000002156 mixing Methods 0.000 claims description 18
- 238000000354 decomposition reaction Methods 0.000 claims description 17
- 239000001814 pectin Substances 0.000 claims description 16
- 229920001277 pectin Polymers 0.000 claims description 16
- 235000010987 pectin Nutrition 0.000 claims description 16
- 239000001648 tannin Substances 0.000 claims description 16
- 229920001864 tannin Polymers 0.000 claims description 16
- 235000018553 tannin Nutrition 0.000 claims description 16
- 235000013305 food Nutrition 0.000 claims description 15
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 claims description 14
- 235000021436 nutraceutical agent Nutrition 0.000 claims description 14
- 239000011230 binding agent Substances 0.000 claims description 13
- 229930190237 caratuberside Natural products 0.000 claims description 13
- 239000002417 nutraceutical Substances 0.000 claims description 13
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 12
- 239000007788 liquid Substances 0.000 claims description 11
- WSLDOOZREJYCGB-UHFFFAOYSA-N 1,2-Dichloroethane Chemical compound ClCCCl WSLDOOZREJYCGB-UHFFFAOYSA-N 0.000 claims description 10
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 claims description 10
- 239000001397 quillaja saponaria molina bark Substances 0.000 claims description 10
- 230000009467 reduction Effects 0.000 claims description 10
- 229930182490 saponin Natural products 0.000 claims description 10
- 238000005406 washing Methods 0.000 claims description 10
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 claims description 9
- 229920002774 Maltodextrin Polymers 0.000 claims description 8
- 239000005913 Maltodextrin Substances 0.000 claims description 8
- 229940035034 maltodextrin Drugs 0.000 claims description 8
- 238000011084 recovery Methods 0.000 claims description 8
- 238000003801 milling Methods 0.000 claims description 7
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 claims description 6
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 claims description 6
- 239000000470 constituent Substances 0.000 claims description 6
- 238000005520 cutting process Methods 0.000 claims description 6
- ZLNQQNXFFQJAID-UHFFFAOYSA-L magnesium carbonate Chemical compound [Mg+2].[O-]C([O-])=O ZLNQQNXFFQJAID-UHFFFAOYSA-L 0.000 claims description 6
- 229910000021 magnesium carbonate Inorganic materials 0.000 claims description 6
- 239000001095 magnesium carbonate Substances 0.000 claims description 6
- 238000002203 pretreatment Methods 0.000 claims description 6
- 239000007921 spray Substances 0.000 claims description 6
- 206010033546 Pallor Diseases 0.000 claims description 5
- 238000004140 cleaning Methods 0.000 claims description 5
- 238000001914 filtration Methods 0.000 claims description 5
- 238000002791 soaking Methods 0.000 claims description 5
- 244000215068 Acacia senegal Species 0.000 claims description 4
- 235000006491 Acacia senegal Nutrition 0.000 claims description 4
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 claims description 4
- 229920000084 Gum arabic Polymers 0.000 claims description 4
- 229920002472 Starch Polymers 0.000 claims description 4
- 235000010489 acacia gum Nutrition 0.000 claims description 4
- 230000003110 anti-inflammatory effect Effects 0.000 claims description 4
- 230000003502 anti-nociceptive effect Effects 0.000 claims description 4
- 238000010438 heat treatment Methods 0.000 claims description 4
- 235000019698 starch Nutrition 0.000 claims description 4
- 239000008107 starch Substances 0.000 claims description 4
- 239000010409 thin film Substances 0.000 claims description 4
- 229920002554 vinyl polymer Polymers 0.000 claims description 4
- 241000208327 Apocynaceae Species 0.000 claims description 3
- WXLJRYSLYQBMGF-RUFGMRSTSA-N CO[C@@H]1[C@@H](O)[C@H](O[C@H]2CC[C@@]3(C)[C@@H](CC[C@@H]4[C@@H]3CC[C@]3(C)[C@H](CC[C@]43O)C(C)=O)C2)O[C@H](C)[C@H]1O[C@@H]1O[C@H](CO)[C@H](O)[C@H](O)[C@H]1O Chemical class CO[C@@H]1[C@@H](O)[C@H](O[C@H]2CC[C@@]3(C)[C@@H](CC[C@@H]4[C@@H]3CC[C@]3(C)[C@H](CC[C@]43O)C(C)=O)C2)O[C@H](C)[C@H]1O[C@@H]1O[C@H](CO)[C@H](O)[C@H](O)[C@H]1O WXLJRYSLYQBMGF-RUFGMRSTSA-N 0.000 claims description 3
- 229920002907 Guar gum Polymers 0.000 claims description 3
- 230000001754 anti-pyretic effect Effects 0.000 claims description 3
- 239000003963 antioxidant agent Substances 0.000 claims description 3
- 230000003078 antioxidant effect Effects 0.000 claims description 3
- 235000006708 antioxidants Nutrition 0.000 claims description 3
- 239000002221 antipyretic Substances 0.000 claims description 3
- 230000002026 carminative effect Effects 0.000 claims description 3
- 239000012141 concentrate Substances 0.000 claims description 3
- 238000009833 condensation Methods 0.000 claims description 3
- 230000005494 condensation Effects 0.000 claims description 3
- 239000003814 drug Substances 0.000 claims description 3
- 235000010417 guar gum Nutrition 0.000 claims description 3
- 239000000665 guar gum Substances 0.000 claims description 3
- 229960002154 guar gum Drugs 0.000 claims description 3
- 239000002002 slurry Substances 0.000 claims description 3
- 208000008589 Obesity Diseases 0.000 claims description 2
- 230000000507 anthelmentic effect Effects 0.000 claims description 2
- 239000008280 blood Substances 0.000 claims description 2
- 210000004369 blood Anatomy 0.000 claims description 2
- 239000000796 flavoring agent Substances 0.000 claims description 2
- 235000019634 flavors Nutrition 0.000 claims description 2
- 239000012530 fluid Substances 0.000 claims description 2
- 235000020824 obesity Nutrition 0.000 claims description 2
- 239000003208 petroleum Substances 0.000 claims description 2
- 150000003839 salts Chemical class 0.000 claims description 2
- JWMFYGXQPXQEEM-NUNROCCHSA-N 5β-pregnane Chemical compound C([C@H]1CC2)CCC[C@]1(C)[C@@H]1[C@@H]2[C@@H]2CC[C@H](CC)[C@@]2(C)CC1 JWMFYGXQPXQEEM-NUNROCCHSA-N 0.000 claims 1
- 206010020772 Hypertension Diseases 0.000 claims 1
- 230000036528 appetite Effects 0.000 claims 1
- 235000019789 appetite Nutrition 0.000 claims 1
- 206010003246 arthritis Diseases 0.000 claims 1
- 230000036772 blood pressure Effects 0.000 claims 1
- 239000003795 chemical substances by application Substances 0.000 claims 1
- 230000002950 deficient Effects 0.000 claims 1
- 206010012601 diabetes mellitus Diseases 0.000 claims 1
- 239000002778 food additive Substances 0.000 claims 1
- 150000002500 ions Chemical class 0.000 claims 1
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 claims 1
- 238000004519 manufacturing process Methods 0.000 claims 1
- 230000002503 metabolic effect Effects 0.000 claims 1
- 238000005549 size reduction Methods 0.000 claims 1
- 229940124597 therapeutic agent Drugs 0.000 claims 1
- 239000013585 weight reducing agent Substances 0.000 claims 1
- 239000000047 product Substances 0.000 description 63
- 239000000843 powder Substances 0.000 description 11
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 9
- 239000000543 intermediate Substances 0.000 description 7
- 238000011143 downstream manufacturing Methods 0.000 description 6
- 239000007858 starting material Substances 0.000 description 6
- 238000000926 separation method Methods 0.000 description 5
- 244000292211 Canna coccinea Species 0.000 description 4
- 241000588724 Escherichia coli Species 0.000 description 4
- 241000607142 Salmonella Species 0.000 description 4
- 230000000694 effects Effects 0.000 description 4
- 229910001385 heavy metal Inorganic materials 0.000 description 4
- 230000000813 microbial effect Effects 0.000 description 4
- 238000013021 overheating Methods 0.000 description 4
- 239000002245 particle Substances 0.000 description 4
- 230000000144 pharmacologic effect Effects 0.000 description 4
- 229910001220 stainless steel Inorganic materials 0.000 description 4
- 239000010935 stainless steel Substances 0.000 description 4
- 238000012360 testing method Methods 0.000 description 4
- 238000013019 agitation Methods 0.000 description 3
- 239000000706 filtrate Substances 0.000 description 3
- 239000012535 impurity Substances 0.000 description 3
- 229960004592 isopropanol Drugs 0.000 description 3
- 238000002386 leaching Methods 0.000 description 3
- 230000007721 medicinal effect Effects 0.000 description 3
- 239000008194 pharmaceutical composition Substances 0.000 description 3
- 238000012545 processing Methods 0.000 description 3
- 238000001179 sorption measurement Methods 0.000 description 3
- AMDCWRHQFJRCAD-UHFFFAOYSA-N 2-[5-hydroxy-6-[[14-hydroxy-17-(1-hydroxyethyl)-10,13-dimethyl-1,2,3,4,5,6,7,8,9,11,12,15,16,17-tetradecahydrocyclopenta[a]phenanthren-3-yl]oxy]-4-methoxy-2-methyloxan-3-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol Chemical compound COC1C(O)C(OC2CC3C(C4C(C5(CCC(C5(C)CC4)C(C)O)O)CC3)(C)CC2)OC(C)C1OC1OC(CO)C(O)C(O)C1O AMDCWRHQFJRCAD-UHFFFAOYSA-N 0.000 description 2
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 2
- 240000007154 Coffea arabica Species 0.000 description 2
- 241001504107 Desmidorchis retrospiciens Species 0.000 description 2
- 230000003178 anti-diabetic effect Effects 0.000 description 2
- 230000002058 anti-hyperglycaemic effect Effects 0.000 description 2
- 230000003276 anti-hypertensive effect Effects 0.000 description 2
- 230000003579 anti-obesity Effects 0.000 description 2
- 230000003356 anti-rheumatic effect Effects 0.000 description 2
- 239000003472 antidiabetic agent Substances 0.000 description 2
- 239000003435 antirheumatic agent Substances 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- 239000013067 intermediate product Substances 0.000 description 2
- 238000011835 investigation Methods 0.000 description 2
- 239000012263 liquid product Substances 0.000 description 2
- 238000000622 liquid--liquid extraction Methods 0.000 description 2
- 238000005457 optimization Methods 0.000 description 2
- JWMFYGXQPXQEEM-WZBAXQLOSA-N pregnane group Chemical group [C@@H]12CC[C@H](CC)[C@@]1(C)CC[C@H]1[C@H]2CCC2CCCC[C@]12C JWMFYGXQPXQEEM-WZBAXQLOSA-N 0.000 description 2
- 238000000638 solvent extraction Methods 0.000 description 2
- 238000001694 spray drying Methods 0.000 description 2
- 238000003860 storage Methods 0.000 description 2
- 238000005979 thermal decomposition reaction Methods 0.000 description 2
- 208000006820 Arthralgia Diseases 0.000 description 1
- 241001504156 Caralluma adscendens Species 0.000 description 1
- 241001504101 Caralluma penicillata Species 0.000 description 1
- 241000284832 Caralluma stalagmifera Species 0.000 description 1
- 241001504021 Caralluma tuberculata Species 0.000 description 1
- 241000178100 Ceropegia attenuata Species 0.000 description 1
- 241001605900 Ceropegia fimbriata Species 0.000 description 1
- 244000295519 Chimaphila umbellata Species 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 241000699670 Mus sp. Species 0.000 description 1
- 241000700159 Rattus Species 0.000 description 1
- 230000006978 adaptation Effects 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 230000002456 anti-arthritic effect Effects 0.000 description 1
- 230000002917 arthritic effect Effects 0.000 description 1
- 230000037396 body weight Effects 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 239000007859 condensation product Substances 0.000 description 1
- 239000000287 crude extract Substances 0.000 description 1
- 230000002939 deleterious effect Effects 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 230000008030 elimination Effects 0.000 description 1
- 238000003379 elimination reaction Methods 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 229930182478 glucoside Natural products 0.000 description 1
- 150000008131 glucosides Chemical class 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 230000037323 metabolic rate Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 230000001766 physiological effect Effects 0.000 description 1
- 239000000419 plant extract Substances 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 235000020071 rectified spirit Nutrition 0.000 description 1
- 238000010992 reflux Methods 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
- A61K31/7034—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
- A61K31/704—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin attached to a condensed carbocyclic ring system, e.g. sennosides, thiocolchicosides, escin, daunorubicin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7008—Compounds having an amino group directly attached to a carbon atom of the saccharide radical, e.g. D-galactosamine, ranimustine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/27—Asclepiadaceae (Milkweed family), e.g. hoya
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/02—Nutrients, e.g. vitamins, minerals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/10—Anthelmintics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A61P39/06—Free radical scavengers or antioxidants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/02—Non-specific cardiovascular stimulants, e.g. drugs for syncope, antihypotensives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Diabetes (AREA)
- Epidemiology (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Molecular Biology (AREA)
- Biotechnology (AREA)
- Alternative & Traditional Medicine (AREA)
- Heart & Thoracic Surgery (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Botany (AREA)
- Cardiology (AREA)
- Rheumatology (AREA)
- Endocrinology (AREA)
- Emergency Medicine (AREA)
- Nutrition Science (AREA)
- Tropical Medicine & Parasitology (AREA)
- Toxicology (AREA)
- Immunology (AREA)
- Physical Education & Sports Medicine (AREA)
- Pain & Pain Management (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Biochemistry (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IN451CH2003 | 2003-06-04 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ZA200509780B true ZA200509780B (en) | 2006-09-27 |
Family
ID=36011983
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ZA200509780A ZA200509780B (en) | 2003-06-04 | 2005-12-01 | Processes for making caralluma extracts and uses |
Country Status (12)
| Country | Link |
|---|---|
| US (2) | US7060308B2 (ko) |
| EP (1) | EP1644013A1 (ko) |
| JP (2) | JP5260873B2 (ko) |
| KR (2) | KR100993487B1 (ko) |
| CN (1) | CN1798566B (ko) |
| AU (2) | AU2004244850B2 (ko) |
| BR (1) | BRPI0411400A (ko) |
| CA (1) | CA2527702C (ko) |
| CO (1) | CO5660269A2 (ko) |
| NZ (2) | NZ573614A (ko) |
| WO (1) | WO2004108148A1 (ko) |
| ZA (1) | ZA200509780B (ko) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20060083795A1 (en) * | 2004-10-19 | 2006-04-20 | Lima Shatkina | Meal replacement products having appetite suppressing qualities |
| KR101307999B1 (ko) * | 2004-12-01 | 2013-09-12 | 니폰 조키 세야쿠 가부시키가이샤 | 건조물 및 그 제조방법 |
| WO2006079056A1 (en) * | 2005-01-20 | 2006-07-27 | Stephen Holt | Herbal compositions containing hoodia |
| AU2006279602B2 (en) * | 2005-08-17 | 2009-06-04 | Elc Management Llc | Delivery system for appetite suppressant |
| MX2009001571A (es) * | 2006-08-17 | 2009-02-19 | Unilever Nv | Proceso para la produccion de la planta de hoodia que contiene glucosidos esteroides. |
| WO2008107910A2 (en) * | 2007-03-05 | 2008-09-12 | Ramaswamy Rajendran | Use of caralluma extracts in the inhibition of adipogenesis and a method of inhibition for the same |
| US8247547B2 (en) * | 2009-01-30 | 2012-08-21 | Ghare Vishwas Sadhu | Process for the preparation of Caralluma extract and a formulation prepared thereof |
| US20130122146A1 (en) * | 2011-11-16 | 2013-05-16 | Decas Botanical Synergies, Llc | Process for Spray Drying Botanical Food |
| US9456916B2 (en) | 2013-03-12 | 2016-10-04 | Medibotics Llc | Device for selectively reducing absorption of unhealthy food |
| US9067070B2 (en) | 2013-03-12 | 2015-06-30 | Medibotics Llc | Dysgeusia-inducing neurostimulation for modifying consumption of a selected nutrient type |
| US9011365B2 (en) | 2013-03-12 | 2015-04-21 | Medibotics Llc | Adjustable gastrointestinal bifurcation (AGB) for reduced absorption of unhealthy food |
| US9884077B2 (en) | 2013-04-30 | 2018-02-06 | Nippon Zoki Pharmaceutical Co., Ltd. | Extract and preparation containing said extract |
| EP2810565A1 (en) * | 2013-06-03 | 2014-12-10 | Dupont Nutrition Biosciences ApS | Antioxidant composition |
| CN103969393A (zh) * | 2014-04-25 | 2014-08-06 | 上海相宜本草化妆品股份有限公司 | 用于化妆品中糖苷类中草药化合物含量测试的前处理方法 |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3960839A (en) * | 1973-02-09 | 1976-06-01 | Escuela Politecnica Nacional | Process for recovering and isolating solasodine and glycosides thereof |
| US5270457A (en) * | 1992-06-12 | 1993-12-14 | University Of Manitoba | Cardiac steriod glycosides |
| HUP0000838A3 (en) | 1997-04-15 | 2001-04-28 | Csir | Extract containing steroid-glucosid, process for its isolation and synthesis, pharmaceutical composition containing it having appetite suppressant activity |
| EP0931550B1 (en) * | 1998-01-26 | 2004-09-22 | National Research Development Corporation, a Government of India Undertaking | A process for the preparation of a spermicidal agent |
| US6703051B1 (en) | 1998-10-13 | 2004-03-09 | Solae, Llc | Process for separating and recovering protein and isoflavones from a plant material |
| US6124442A (en) * | 1999-03-24 | 2000-09-26 | Zhou; James H. | Process for extracting triterpene glycosides from botanical sources |
| US6224906B1 (en) * | 1999-08-31 | 2001-05-01 | Natreon Inc. | St. John's wort composition |
| US6635758B2 (en) * | 2000-09-25 | 2003-10-21 | Industrial Technology Research Institute | Process for extracting glycoside using an aqueous two-phase system |
| US7008648B2 (en) * | 2001-11-16 | 2006-03-07 | Novartis Nutrition Ag | Plant derived or derivable material with appetite suppressing activity |
-
2004
- 2004-05-04 US US10/837,613 patent/US7060308B2/en not_active Expired - Lifetime
- 2004-05-31 KR KR1020077024499A patent/KR100993487B1/ko active IP Right Grant
- 2004-05-31 CA CA2527702A patent/CA2527702C/en not_active Expired - Lifetime
- 2004-05-31 JP JP2006508488A patent/JP5260873B2/ja not_active Expired - Lifetime
- 2004-05-31 CN CN200480015265.3A patent/CN1798566B/zh not_active Expired - Lifetime
- 2004-05-31 BR BRPI0411400-0A patent/BRPI0411400A/pt not_active Application Discontinuation
- 2004-05-31 EP EP04735495A patent/EP1644013A1/en not_active Ceased
- 2004-05-31 NZ NZ573614A patent/NZ573614A/en unknown
- 2004-05-31 WO PCT/IN2004/000150 patent/WO2004108148A1/en active Application Filing
- 2004-05-31 AU AU2004244850A patent/AU2004244850B2/en not_active Expired
- 2004-05-31 NZ NZ543995A patent/NZ543995A/en unknown
- 2004-05-31 KR KR1020057023343A patent/KR20060034229A/ko not_active Application Discontinuation
-
2005
- 2005-03-18 US US11/083,226 patent/US7390516B2/en active Active
- 2005-12-01 ZA ZA200509780A patent/ZA200509780B/en unknown
- 2005-12-02 CO CO05122635A patent/CO5660269A2/es not_active Application Discontinuation
-
2008
- 2008-12-12 AU AU2008255233A patent/AU2008255233B2/en not_active Expired
-
2012
- 2012-11-22 JP JP2012256942A patent/JP2013067638A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| CO5660269A2 (es) | 2006-07-31 |
| CN1798566A (zh) | 2006-07-05 |
| JP2006526615A (ja) | 2006-11-24 |
| JP5260873B2 (ja) | 2013-08-14 |
| AU2004244850A1 (en) | 2004-12-16 |
| BRPI0411400A (pt) | 2006-07-25 |
| AU2004244850A2 (en) | 2004-12-16 |
| US20040247702A1 (en) | 2004-12-09 |
| CN1798566B (zh) | 2014-03-12 |
| AU2004244850B2 (en) | 2009-01-08 |
| AU2008255233A1 (en) | 2009-01-22 |
| KR20060034229A (ko) | 2006-04-21 |
| US7390516B2 (en) | 2008-06-24 |
| AU2008255233B2 (en) | 2012-01-12 |
| EP1644013A1 (en) | 2006-04-12 |
| CA2527702C (en) | 2016-03-08 |
| KR20070114833A (ko) | 2007-12-04 |
| KR100993487B1 (ko) | 2010-11-10 |
| US7060308B2 (en) | 2006-06-13 |
| NZ573614A (en) | 2011-02-25 |
| WO2004108148A1 (en) | 2004-12-16 |
| JP2013067638A (ja) | 2013-04-18 |
| US20050163871A1 (en) | 2005-07-28 |
| CA2527702A1 (en) | 2004-12-16 |
| NZ543995A (en) | 2009-02-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2008255233B2 (en) | Processes for making caralluma extracts and uses | |
| JP2006526615A5 (ko) | ||
| EP2131681B1 (en) | Process for producing refined nutraceutic extracts from artichoke waste and from other plants of the cynara genus | |
| CN111117773A (zh) | 一种从蒜头果油中分离神经酸的方法及应用 | |
| EP2359839A2 (en) | Method for preparing extract fraction reinforced with ginsenosides rg1 or rb1 from ginseng | |
| KR101625474B1 (ko) | 진세노사이드 알에이치4의 대량 제조방법 | |
| CN108524668B (zh) | 一种对药物性肝损伤具有修复和治疗作用的枸杞提取物的制备方法 | |
| JP3507115B2 (ja) | バナバ葉抽出物と抗糖尿病剤 | |
| KR20100043723A (ko) | 원적외선 처리를 통한 프로토페낙사디올 진세노사이드 성분이 증가된 인삼 잎의 제조방법 | |
| CN114470101A (zh) | 中药组合物及其制备方法、含其的口服剂 | |
| MXPA05013031A (en) | Processes for making caralluma extracts and uses | |
| CN103751242A (zh) | 生产水牛掌属植物萃取物 | |
| US8247547B2 (en) | Process for the preparation of Caralluma extract and a formulation prepared thereof | |
| KR20230034674A (ko) | 생잎을 이용한 돌외잎차의 제조방법 및 이에 따라 제조된 돌외잎차를 이용한 돌외잎차 추출물의 제조방법 | |
| SOLUNKE et al. | Standardization and selection of organic solvent and extraction parameters for charantin in bitter gourd (Momordica charantin L.) fruits | |
| CA3067807A1 (en) | Tongkat ali extract production processes and uses thereof | |
| CN115282635A (zh) | 一种迷迭香粗提物及其制备方法和应用 | |
| KR20240097072A (ko) | 천연결합제를 첨가한 다이어트용 식품 제조법 | |
| CN117257891A (zh) | 用于提高内源类胰岛素样生长因子1分泌的植物提取物药物组合物 | |
| CN114788842A (zh) | 一种具有降糖活性的组合物 | |
| JPH0769911A (ja) | 血中中性脂肪改善剤及びその製造方法並びにこれを含有する組成物 | |
| CN106243236A (zh) | 一种血蛤提取物制品的制备方法 | |
| WO2013183064A2 (en) | Extraction of phytochemicals from trichilia connaroides | |
| JPS62246591A (ja) | ギムネマ・シルベスタ有効成分抽出物の製造法 |